iECURE (Series A-1)
Funding Details
- Awarder
- Inbox
- Date Award
- November 30, 2022
- Vertical
- Gene Editing
- Funding URL
- View Funding Page
- Funding Amount:
- $65,000,000
Company Info
- Founders
- Joseph Truitt
- Company Description
- iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
- Market
- Liver Disorders
- Location
- Plymouth Meeting, PA, USA
- Coinvestors
- LYFE Capital, Novo Holdings, OrbiMed Advisors, Versant Ventures